Neoprenewel (Indapamide, Perindopril Arginine)

Indapamide, the active ingredient in Neoprenewel, is a combination diuretic and ACE inhibitor presented as an oral tablet formulation for oral use. It is employed to lower elevated blood pressure in adult patients with hypertension, often in combination with lifestyle measures.

GNH USA supplies Neoprenewel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing and regulatory‑aligned distribution for this antihypertensive combination product.

Neoprenewel, a combination diuretic and ACE‑inhibitor, is indicated for the management of hypertension.

- Essential hypertension: helps achieve target blood pressure levels. - Primary hypertension: contributes to long‑term cardiovascular risk reduction. - High blood pressure: assists in maintaining stable hemodynamics.

Common Side Effects: - Dizziness: sensation of light‑headedness, especially after standing. - Headache: mild to moderate pain in the head region. - Cough: dry, persistent throat irritation. - Increased urination: more frequent need to void. - Electrolyte imbalance: changes in potassium or sodium levels. - Fatigue: feeling unusually tired or weak.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue, or throat that may compromise breathing. - Severe hypotension: markedly low blood pressure causing faintness or shock. - Renal impairment: decreased kidney function indicated by rising creatinine. - Hyperkalemia: elevated potassium levels that can affect heart rhythm. - Pancreatitis: inflammation of the pancreas presenting with abdominal pain.

Before initiating therapy, clinicians should consider several safety measures. - Blood pressure monitoring: ensure adequate control and avoid excessive drops. - Renal function assessment: evaluate serum creatinine and eGFR regularly. - Electrolyte surveillance: check potassium and sodium levels, especially when combined with other diuretics. - ACE‑inhibitor hypersensitivity: avoid in patients with known angioedema or cough related to ACE inhibitors. - Pregnancy and lactation: use only if clearly needed after risk‑benefit evaluation. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Neoprenewel may interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Aliskiren: concurrent use with ACE inhibitors can increase risk of renal dysfunction. - Potassium‑sparing diuretics or supplements: may cause dangerous hyperkalemia. - Lithium: ACE inhibition can raise lithium levels, risking toxicity.

Moderate Interactions (Monitor Closely): - NSAIDs: can blunt antihypertensive effect and affect renal function. - Thiazide‑type diuretics: additive diuretic effect may lead to volume depletion. - Beta‑blockers: may enhance blood‑pressure lowering, requiring dose adjustments.